The recent surge in Hims & Hers Health Inc.'s shares can be attributed to the company’s announcement that it has inked a deal to sell Novo Nordisk's weight-loss drug, Wegovy, on its telehealth ...

After going after the companies making compounded versions of their drugs, GLP-1 makers are now going into business with the online telehealth sites that were previously selling the copycats.

Novo Nordisk has sought strength in numbers in the battle for telehealth obesity drug sales in the US, enlisting the aid of ...